Pages that link to "Q47953579"
Jump to navigation
Jump to search
The following pages link to Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers (Q47953579):
Displaying 35 items.
- Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine (Q24632671) (← links)
- Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system (Q24646305) (← links)
- Acute migraine: Current treatment and emerging therapies (Q24654649) (← links)
- Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks. (Q30988780) (← links)
- Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review (Q33516651) (← links)
- Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974) (Q33524521) (← links)
- Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis (Q34094599) (← links)
- Attenuation of cartilage degeneration by calcitonin gene-related paptide receptor antagonist via inhibition of subchondral bone sclerosis in osteoarthritis mice (Q34505877) (← links)
- Modelling the anti-migraine effects of BIBN 4096 BS: a new calcitonin gene-related peptide receptor antagonist (Q34542202) (← links)
- CGRP receptor antagonists: an expanding drug class for acute migraine? (Q34637610) (← links)
- Migraine: current concepts and emerging therapies (Q36229186) (← links)
- Emerging drugs for migraine prophylaxis and treatment. (Q36574510) (← links)
- Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists. (Q36936344) (← links)
- Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF. (Q37155633) (← links)
- Current and prospective pharmacological targets in relation to antimigraine action (Q37216396) (← links)
- Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inhalation injury (Q37264623) (← links)
- Calcitonin gene-related peptide receptor antagonists for migraine (Q37756158) (← links)
- Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies (Q38130336) (← links)
- CGRP antagonists and antibodies for the treatment of migraine. (Q38248953) (← links)
- Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors. (Q38254099) (← links)
- Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus (Q39948717) (← links)
- Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine (Q40276569) (← links)
- CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine. (Q42854065) (← links)
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers (Q43885764) (← links)
- BMS-927711 for the acute treatment of migraine (Q45137898) (← links)
- Mechanisms mediating the enhanced gene transcription of P2X3 receptor by calcitonin gene-related peptide in trigeminal sensory neurons (Q46609476) (← links)
- Side effects associated with current and prospective antimigraine pharmacotherapies. (Q47309054) (← links)
- Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity (Q47973283) (← links)
- CGRP and its receptors (Q48198655) (← links)
- Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs (Q49355607) (← links)
- Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy. (Q55084349) (← links)
- Migraine: Advances in the pathophysiology and treatment (Q83613450) (← links)
- [Pain-relieving effect of CGRP antagonism on inflammatory pain] (Q85245886) (← links)
- Characterization of the effects of calcitonin gene-related peptide receptor antagonist for Alzheimer's disease (Q89955963) (← links)
- Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine (Q91993175) (← links)